Webinar | June 18, 2024

Advancing Early-Stage Bispecific Discovery Programs Towards Clinical Success

Source: Lonza

Discover how Lonza's innovative tools can accelerate your bispecific antibody development. Dr. Jin Lu shares insights and expertise in this webinar.

Lonza's GS Discovery® transient expression platform can boost transient titers by ~30-fold to enable rapid early material supply and streamline the transition from discovery to stable production. In addition, Lonza's bYlok® technology increases bispecific yields and simplifies downstream processing by driving correct heavy-light chain pairing to >95%.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Lonza